Vranckx P, Halvorsen S (2025)
Cracking the Clot: The RIVAWAR Trial Challenges Warfarin's Reign in Left Ventricular Thrombus Post-Acute Coronary Syndrome
Eur Heart J Acute Cardiovasc Care (in press)
DOI 10.1093/ehjacc/zuaf052, PubMed 40171935

Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R (2025)
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvaf006, PubMed 40145128

Alexander JH, Lydon EJ, Piccini JP, Viethen T, Oldgren J, Goodman SG, Steffel J, Russo AM, van Gelder IC, Ferdinand KC, Lopes RD, Mundl H, Benczur B, Gómez-Doblas JJ, Glikson M, Goudev A, Grove EL, Halvorsen S, Kiviniemi T, Martin AC, Sandhu RK, Vinereanu D, Rockhold FW, Caso V, Coppolecchia R et al. (2025)
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial
JAMA Cardiol (in press)
DOI 10.1001/jamacardio.2025.0277, PubMed 40136309